Analysis of the Adverse Reactions and Risk Factors of Apatinib in the Treatment of Breast Cancer in Real World

MA Ying-lin, LE Kai-di, YAN Jia-qing, TIAN Chun-hua, WANG Tao, LIU Min, LI Guo-hui

Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (4) : 310-314.

PDF(991 KB)
PDF(991 KB)
Chinese Pharmaceutical Journal ›› 2022, Vol. 57 ›› Issue (4) : 310-314. DOI: 10.11669/cpj.2022.04.011

Analysis of the Adverse Reactions and Risk Factors of Apatinib in the Treatment of Breast Cancer in Real World

  • {{article.zuoZhe_EN}}
Author information +
History +

HeighLight

{{article.keyPoints_en}}

Abstract

{{article.zhaiyao_en}}

Key words

QR code of this article

Cite this article

EndNote

Ris (Procite)

Bibtex

Download Citations
{{article.zuoZheEn_L}}. {{article.title_en}}[J]. {{journal.qiKanMingCheng_EN}}, 2022, 57(4): 310-314 https://doi.org/10.11669/cpj.2022.04.011

References

Publishing order | Descend order by publishing year | Descend order by cited within

References

{{article.reference}}

Funding

RIGHTS & PERMISSIONS

{{article.copyrightStatement_en}}
{{article.copyrightLicense_en}}
PDF(991 KB)

Accesses

Citation

Detail
Sections
Recommended

/

〈 〉